Welcome to our dedicated page for Curaleaf Holdings SEC filings (Ticker: CURLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Curaleaf Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Curaleaf Holdings's regulatory disclosures and financial reporting.
Curaleaf Holdings, Inc., a global cannabis company, reported stronger results for the six months ended June 30, 2026. Net revenues were 664,330 (in thousands) versus 617,211 a year earlier, with gross profit of 327,204 (in thousands). Net income attributable to Curaleaf was 82,306 (in thousands), compared with a net loss of 114,222 (in thousands), or basic EPS of $0.32 versus a loss of $0.55. For the second quarter, net revenues were 340,099 (in thousands) and net income was 12,507 (in thousands).
Performance benefited from a large income tax benefit of 137,489 (in thousands), compared with a prior-year tax provision, while interest expense on debt and lease obligations totaled 53,242 (in thousands) for the first half. Total assets were 2,814,357 (in thousands), including cash and restricted cash of 106,968 (in thousands) and inventories of 244,724 (in thousands). Total liabilities were 1,946,897 (in thousands), including notes payable of 611,541 (in thousands) and an uncertain tax position of 468,485 (in thousands). Shareholders’ equity rose to 867,460 (in thousands) as redeemable non‑controlling interests were eliminated.
Operating cash flow from continuing operations was 50,305 (in thousands). After a 1‑for‑3 reverse stock split, there were 233,484,263 subordinate voting shares and 31,323,568 multiple voting shares outstanding, and the company operated 173 U.S. dispensaries plus international cultivation, manufacturing and distribution platforms.
Curaleaf Holdings, Inc., a British Columbia corporation and foreign private issuer, furnished corporate governing documents under U.S. securities reporting rules. These include a Notice of Articles, consolidated Articles effective June 23, 2026, a Coattail Agreement, an Insider Trading Policy, and several debt-related indenture and loan amendments.
The Articles confirm an unlimited authorized share structure of Subordinate Voting Shares, Multiple Voting Shares and Exchangeable Shares, all without par value. Subordinate Voting Shares carry one vote per share, participate rateably with Multiple Voting Shares in dividends and liquidation on an as-converted basis, and do not carry pre-emptive rights. Multiple Voting Shares carry 15 votes per share and any change to their rights requires a separate special resolution of their holders.
Shareholder protections include coattail provisions allowing Subordinate Voting Shares to temporarily convert into Multiple Voting Shares to participate in qualifying takeover offers, then re-convert if the offer does not complete, and a standing right to convert Subordinate Voting Shares into Exchangeable Shares on a one-for-one basis. Exhibits also include a Third Supplemental Indenture dated January 17, 2025 governing 10.00% Senior Secured Notes due December 17, 2027 and a February 18, 2026 first amendment, consent and waiver to an amended and restated loan agreement with Needham Bank.
Curaleaf Holdings, Inc. is expanding its Florida presence by opening a new medical cannabis dispensary in Edgewater on July 17, 2026. This location increases its Florida footprint to 74 dispensaries and brings its total U.S. store count to 166 locations, reinforcing its role as a large multi-state operator.
The Edgewater site will offer multiple Curaleaf brands and product formats, including Reef flower, Anthem pre-rolls, Dark Heart and Grassroots premium flower, and new Select Briq 2 vapes. Management highlights a focus on serving Florida’s medical cannabis community, which represents about 4% of the state population. A grand opening celebration with promotions and events is scheduled for July 24–25, 2026.
Curaleaf Holdings, Inc. reports that Spain’s medicines regulator, AEMPS, has formally approved the registration of two standardized cannabis preparations, one THC‑dominant and one CBD‑dominant, developed by its Spanish manufacturing subsidiary. These registrations, listed as CAN‑1 and CAN‑2, are the first under Spain’s new medicinal cannabis framework, Royal Decree 903/2025, and clear the path for supply to hospital pharmacies for use in magistral formulas pursuant to medical prescription.
The milestone builds on Curaleaf’s EU‑GMP certified manufacturing facility and R&D laboratory in Alicante and on Medalchemy SL’s 2020 AEMPS license to process medicinal cannabis derivatives. Spain, a country of nearly 50 million people, is described as central to Curaleaf’s vision for Europe. The preparations are expected to become available to patients through hospital pharmacies in due course, in line with the new framework and subject to actions by Spanish health authorities.
Curaleaf Holdings, Inc. reported a capital-markets milestone: exchange-traded options on its subordinate voting shares are expected to begin trading on the Montréal Exchange on July 13, 2026 under the symbol CURA.
The listing is initiated solely by the Exchange and involves no new share issuance, no dilution, and no proceeds to Curaleaf. The company believes listed options may enhance liquidity and price discovery and expand investor tools for hedging, income, and directional strategies, particularly for institutional and derivatives-focused investors.
Curaleaf Holdings reports that its Subordinate Voting Shares have resumed trading under the OTCQX symbol CURLF, effective July 6, 2026. The shares had temporarily traded under CURLD for a 20-trading-day transition period following a previously announced 1-for-3 reverse stock split effective June 5, 2026.
The return to the original CURLF symbol is an administrative change and requires no action from shareholders. Curaleaf’s shares continue to trade on the Toronto Stock Exchange under the symbol CURA and on the OTCQX Best Market under CURLF, both under the post-split CUSIP 23126M300.
Curaleaf Holdings, Inc. will release its financial and operating results for the second quarter ended June 30, 2026 after market close on August 5, 2026. The company will host a conference call and webcast at 5:00 p.m. ET that day, followed by a Q&A session.
A replay will be available by dial-in through August 12, 2026. Curaleaf describes itself as a leading international provider of cannabis consumer products, operating well-known brands across medical and adult-use markets in North America and Europe and listing its shares on the Toronto Stock Exchange and OTCQX.
Curaleaf Holdings reported results of its 2026 annual general and special shareholders meeting, where 1.71 billion votes were cast. Shareholders approved an amendment to the articles removing the automatic conversion feature of the Company’s Multiple Voting Shares after a U.S. stock exchange listing, with strong support across all voting classes.
They also approved an exchange program under which up to 10,070,478 stock options with exercise prices or performance conditions at or above US$5.00 can be exchanged for restricted share units under the 2018 Stock and Incentive Plan. In addition, shareholders backed a plan of arrangement to continue the Company from British Columbia to the State of Delaware, subject to court approval.
All seven nominated directors were elected with more than 97% support each, BDO USA, P.C. was reappointed as auditor, and shareholders approved continued use of the long-term incentive plan and related unallocated awards.
Curaleaf Holdings has filed a supplement to its management information circular ahead of its June 22, 2026 annual and special meeting. Shareholders are being asked to approve an amendment to the Company’s articles that would remove the automatic conversion trigger tied to a future U.S. stock exchange listing for multiple voting shares held by CEO and Chairman Boris Jordan, preserving the dual-class structure beyond any such listing.
The Board approved the amendment by majority, with one director opposing on the basis that it was not necessary and could have led to an unfavorable market reaction; the Company notes there was no discernible reaction after the announcement. A Special Committee reviewed alternatives, confirmed retained ownership-based sunsets and MI 61-101 “majority of the minority” protections, and chose not to hire separate legal counsel. Curaleaf also extends the proxy cut-off so shareholders can vote their Subordinate Voting Shares up to 3:00 p.m. Eastern time on June 19, 2026.
Curaleaf Holdings, Inc. has implemented a reverse stock split of its subordinate voting shares, converting three pre-split shares into one post-split share. The change took effect at the start of trading on June 5, 2026, after board approval.
The company also consolidated its multiple voting shares at the same three-to-one ratio to keep the relative rights between share classes unchanged. Subordinate voting shares outstanding moved from 698,731,895 pre-split to approximately 232,910,632 post-split, with fractional shares rounded up or down to the nearest whole share.